232 related articles for article (PubMed ID: 11157561)
1. Expression of specific matrix metalloproteinases in inflammatory myopathies.
Kieseier BC; Schneider C; Clements JM; Gearing AJ; Gold R; Toyka KV; Hartung HP
Brain; 2001 Feb; 124(Pt 2):341-51. PubMed ID: 11157561
[TBL] [Abstract][Full Text] [Related]
2. Expression of matrix metalloproteinases and tissue inhibitors of metalloproteinases in human optic nerve head astrocytes.
Agapova OA; Ricard CS; Salvador-Silva M; Hernandez MR
Glia; 2001 Mar; 33(3):205-16. PubMed ID: 11241738
[TBL] [Abstract][Full Text] [Related]
3. Dynamic expression of mRNAs and proteins for matrix metalloproteinases and their tissue inhibitors in the primate corpus luteum during the menstrual cycle.
Young KA; Hennebold JD; Stouffer RL
Mol Hum Reprod; 2002 Sep; 8(9):833-40. PubMed ID: 12200461
[TBL] [Abstract][Full Text] [Related]
4. Coordinate expression of matrix-degrading proteinases and their activators and inhibitors in bovine skeletal muscle.
Balcerzak D; Querengesser L; Dixon WT; Baracos VE
J Anim Sci; 2001 Jan; 79(1):94-107. PubMed ID: 11204721
[TBL] [Abstract][Full Text] [Related]
5. Elevated ratio of MMP2/MMP9 activity is associated with poor response to chemotherapy in osteosarcoma.
Kunz P; Sähr H; Lehner B; Fischer C; Seebach E; Fellenberg J
BMC Cancer; 2016 Mar; 16():223. PubMed ID: 26979530
[TBL] [Abstract][Full Text] [Related]
6. Expression of matrix metalloproteinases in the muscle of patients with inflammatory myopathies.
Choi YC; Dalakas MC
Neurology; 2000 Jan; 54(1):65-71. PubMed ID: 10636127
[TBL] [Abstract][Full Text] [Related]
7. [Significance of imbalance between matrix metalloproteinases and tissue type inhibitor of metalloproteinases in renal tubulointerstitial lesions of aging rats].
Chen RQ; Chen XM; Cui SW; Cai GY; Shi SZ; Xie YS; Lu Y; Peng LX
Zhonghua Yi Xue Za Zhi; 2004 Jun; 84(11):937-42. PubMed ID: 15329283
[TBL] [Abstract][Full Text] [Related]
8. Expression and activity of matrix metalloproteases in human malignant mesothelioma cell lines.
Liu Z; Ivanoff A; Klominek J
Int J Cancer; 2001 Mar; 91(5):638-43. PubMed ID: 11267973
[TBL] [Abstract][Full Text] [Related]
9. Spatiotemporal expression patterns of metalloproteinases and their inhibitors in the postnatal developing rat cerebellum.
Vaillant C; Didier-Bazès M; Hutter A; Belin MF; Thomasset N
J Neurosci; 1999 Jun; 19(12):4994-5004. PubMed ID: 10366632
[TBL] [Abstract][Full Text] [Related]
10. [Expression of matrix metalloproteinases-9,2,7,and tissue inhibitor of metalloproteinases-1,2,3 mRNA in ovarian tumors and their clinical significance].
Hu XX; Li L; Li DR; Zhang W; Cheng XQ; Zhang JQ; Tang BJ
Ai Zheng; 2004 Oct; 23(10):1194-8. PubMed ID: 15473934
[TBL] [Abstract][Full Text] [Related]
11. Expression of matrix metalloproteinases 2 and 9 and tissue inhibitors of metalloproteinase 1 and 2 in inflammation-induced corneal neovascularization.
Ma DH; Chen JK; Kim WS; Hao YX; Wu HC; Tsai RJ; Hwang DG; Zhang F
Ophthalmic Res; 2001; 33(6):353-62. PubMed ID: 11721189
[TBL] [Abstract][Full Text] [Related]
12. Differential expression of matrix metalloproteinases and tissue inhibitors and extracellular matrix remodeling in aortic regurgitant hearts.
Truter SL; Catanzaro DF; Supino PG; Gupta A; Carter J; Herrold EM; Dumlao TF; Borer JS
Cardiology; 2009; 113(3):161-8. PubMed ID: 19129699
[TBL] [Abstract][Full Text] [Related]
13. Matrix metalloproteinases and their inhibitors in the nasal mucosa of patients with perennial allergic rhinitis.
Shaida A; Kenyon G; Devalia J; Davies RJ; MacDonald TT; Pender SL
J Allergy Clin Immunol; 2001 Nov; 108(5):791-6. PubMed ID: 11692106
[TBL] [Abstract][Full Text] [Related]
14. Correlation between MMPs and their inhibitors in breast cancer tumor tissue specimens and in cell lines with different metastatic potential.
Figueira RC; Gomes LR; Neto JS; Silva FC; Silva ID; Sogayar MC
BMC Cancer; 2009 Jan; 9():20. PubMed ID: 19144199
[TBL] [Abstract][Full Text] [Related]
15. Expression of tissue inhibitor of metalloproteinase-1, -2, and -3 during neointima formation in organ cultures of human saphenous vein.
Kranzhöfer A; Baker AH; George SJ; Newby AC
Arterioscler Thromb Vasc Biol; 1999 Feb; 19(2):255-65. PubMed ID: 9974405
[TBL] [Abstract][Full Text] [Related]
16. Involvement of matrix metalloproteinases (MMP-2, -7, -9) and their tissue inhibitors (TIMP-2, -3) in the chicken oviduct regression and recrudescence.
Leśniak-Walentyn A; Hrabia A
Cell Tissue Res; 2016 Nov; 366(2):443-454. PubMed ID: 27342592
[TBL] [Abstract][Full Text] [Related]
17. Metalloproteinase and inhibitor expression profiling of resorbing cartilage reveals pro-collagenase activation as a critical step for collagenolysis.
Milner JM; Rowan AD; Cawston TE; Young DA
Arthritis Res Ther; 2006; 8(5):R142. PubMed ID: 16919164
[TBL] [Abstract][Full Text] [Related]
18. Differential expression of matrix metalloproteinases and their tissue-derived inhibitors in cutaneous wound repair.
Soo C; Shaw WW; Zhang X; Longaker MT; Howard EW; Ting K
Plast Reconstr Surg; 2000 Feb; 105(2):638-47. PubMed ID: 10697171
[TBL] [Abstract][Full Text] [Related]
19. Expression of metalloproteinases and their tissue inhibitors in gingiva affected by hereditary gingival fibromatosis: analysis of three cases within a family.
Gonçalves Lda R; Oliveira GA; Borojevic R; Otazu IB; Feres-Filho EJ
J Periodontal Res; 2009 Dec; 44(6):714-7. PubMed ID: 19453853
[TBL] [Abstract][Full Text] [Related]
20. Matrix metalloproteinases in inflammatory myopathies: enhanced immunoreactivity near atrophic myofibers.
Schoser BG; Blottner D; Stuerenburg HJ
Acta Neurol Scand; 2002 Apr; 105(4):309-13. PubMed ID: 11939944
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]